Cite
HARVARD Citation
Hu, J. et al. (2019). Efficacy of Nifekalant in Patients With Wolff‐Parkinson‐White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings. Journal of the American Heart Association. 8 (13), p. n/a. [Online].